18-11-2005: Thermo Electron Corporation announced that it had secured a major contract with Altana Pharma to install a fully integrated Ultra High Throughput Screening system. Named last year as one of the most profitable pharmaceutical operations in Europe, Altana focuses on identifying new therapeutic approaches in the fields of respiratory inflammation, oncology and gastroenterology. The new system promises to significantly accelerate this complex process, shortening both compound discovery and development times.
Compound screening and profiling in early drug discovery is currently the responsibility of Altana's HTS laboratories in Konstanz, Germany. Using cell and biochemical based assays, the laboratories focus on small volume 384 and 1536-well plates. According to Christopher McNary, Vice President & General Manager Laboratory Automation Solutions Thermo Electron, Thermo will be installing its CRS Dimension4 System, which consists of advanced robotics developed to maximize throughput in the laboratory. Thermo's CRS Dimension4 will integrate other Thermo equipment such as Multidrop® liquid dispensers and VAL's (vertical array loaders) with Thermo's Cytomat incubators to maximize storage capacity.
Dr. Stuermer, Head of High Throughput Screening, Altana Pharma commented, "We have very tough criteria for the production of high quality data and the need of an ultra high throughput system that can deliver a large number of test points per day. We felt that Thermo is the company that can fulfill our specific requirements with a robust, highly automated system." At present, up to 80,000 compounds are screened per day, but following the integration of the CRS Dimension4 System, they anticipate being able to significantly improve these capabilities to more than 180,000 compound tests per day. Dr. Stuermer also believes that the integration of such a system will boost compound profiling capabilities from currently 10,000 IC50s per day to a whole new level.
This is where you can add this news to your personal favourites
The shareholders of ALTANA AG approved the sale of ALTANA Pharma to Nycomed at the Extraordinary General Meeting in Frankfurt. In his speech, Dr. Nikolaus Schweickart, President and CEO of ALTANA AG, explained to the shareholders the main reasons for the sale of the pharmaceuticals business ... more
ALTANA AG has announced that the European and U.S. antitrust authorities have approved the acquisition of ALTANA's pharmaceuticals business by Nycomed without conditions.
ALTANA AG announced the sale of ALTANA Pharma AG and its entire pharmaceuticals business to Nycomed on September 21, 20 ... more
ALTANA AG announced the sale of ALTANA Pharma AG and its entire pharmaceuticals business to Nycomed. The Supervisory Board of ALTANA AG has approved this transaction. The completion of the transaction is subject to approval by the competent antitrust authorities in the EU and the U.S. It is ... more
Thermo Fisher Scientific announced that its informatics solutions have won Scientific Computing's 2007 Readers' Choice Awards in four categories - more than any other vendor. The awards represent the company's end-to-end informatics offering including CDS (Chromatography Data Systems), Spec ... more
Thermo Electron Corporation and Fisher Scientific International Inc. announced that the merger of the two companies has been completed, creating Thermo Fisher Scientific Inc.. The companies combined in a tax-free, stock-for-stock transaction following anti-trust clearance received from the ... more
Thermo Electron Corporation has established a new local customer support center for its informatics software and services in Dammam, in the Eastern province of Saudi Arabia. The new helpdesk has been developed in close collaboration with the Yusuf Bin Ahmed Kanoo group, Thermo's partner in ... more